Featured in the Tampa Bay Times: Kaligia Bioscience’s CEO, Fazal Fazlin, discussing clinical trials for a saliva test that can detect COVID-19 in just three minutes.
Previous PostKaligia Biosciences' COVID-19 Clinical Trials Begin - Tampa Bay Times
Next PostMilestone Achieved: FDA Approves Clinical Testing
